VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BRKRBruker Corporation
$60.91$9.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBRKRCash Flow

Bruker Corporation (BRKR) Cash Flow Statement

27Y historyFree accessUpdated daily

Cash generation remains highly unstable, evidenced by a free cash flow margin that swung from 21.2% in 2025Q4 to a negative 18.7% in 2025Q2 due to volatile working capital requirements.

BRKR Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations140.3M134.1M251.3M350.1M274.4M282.4M332.2M213.4M239.7M154.4M130.8M229.2M114.3M145M133.1M87.7M156.1M149.8M106.9M28.21M37.69M42.19M-889K-6.08M-11.39M-11.47M-202K5.44M
Operating CF Margin %-3.9%7.46%11.81%10.84%11.68%16.71%10.3%12.65%8.74%8.12%14.12%6.32%7.88%7.43%5.31%11.96%13.44%9.66%5.15%8.65%14.18%-0.31%-2.33%-9.79%-12.38%-0.26%8.4%
Operating CF Growth %-11846.88%-46.64%-28.22%27.59%-2.83%-14.99%55.67%-10.97%55.25%18.04%-42.93%100.52%-21.17%8.94%51.77%-43.82%4.21%40.13%278.96%-25.16%-10.67%4846.12%85.39%46.58%0.74%-5580.69%-103.72%-
Net Income-11.6M29.2M113.8M427.2M298.5M280.6M161.4M198M181M80.3M154.5M104.9M59.6M81.8M78.2M94M96.8M81M64.9M31.53M18.48M3.65M-7.83M-17.55M-6.2M3.64M2.25M1.25M
Depreciation & Amortization228.2M220.3M183.8M114.9M88.7M89.1M80.5M75.6M64.9M63.9M54.3M53.3M59.7M61.3M59.1M3M36.1M29.7M29.9M12.63M13.29M8.61M9.79M16.87M8.2M6.04M4.14M3.49M
Stock-Based Compensation0025.3M24M27.7M17.2M16M9.6M11.3M11M9.4M8M9.4M6.6M7.8M7.9M6.9M6.3M4.5M2.16M1.47M24K2K-100K-39K238K00
Deferred Taxes-81.8M-104.5M-63.8M-24.4M-14.8M-5.8M-22.5M-5.4M-15.1M28.2M-26.9M-29.4M-9.2M14M-11.7M-4.8M-3.6M-2.9M-2.3M-2.03M1.41M-2.19M211K3.37M-1.6M249K-3.34M0
Other Non-Cash Items224.8M133.7M70.4M-103.8M18.4M26.5M27.2M10.1M39.8M11.6M24.1M46.1M34.1M33.9M58M89.6M26.3M-800K-300K1.71M-5.54M195K3.44M2.78M10.51M-356K1.15M1.1M
Working Capital Changes-221.5M-144.6M-78.2M-87.8M-144.1M-125.2M69.6M-74.5M-42.2M-40.6M-84.6M46.3M-39.3M-52.6M-58.3M-102M-6.4M36.5M10.2M-17.79M8.57M31.91M-6.5M-11.45M-22.26M-21.28M-4.41M-395.65K
Change in Receivables00-40.6M-900K-67.9M-95.3M40.8M-5M-30.5M-55.5M-8.4M45M-14.5M-19.3M1.6M-52.8M-27.3M-9.4M33M-28.08M-5.78M-3.1M4.56M-10.61M-8.96M-5.91M00
Change in Inventory-47.2M0-69.8M-125M-137.9M-67M-91.6M-60.2M-35.5M-6.6M-43.2M-5.4M4.6M5.7M-49.5M-111.7M-68M21.7M8M-26.22M-11.68M4.84M8.3M-1.27M-14.86M-15.29M-13.03M-10.26M
Change in Payables11.2M-86M20.8M23.1M33.3M61.8M-2.4M15.9M6.2M33.7M-19.6M12.6M9M7M4.6M9.2M6.5M5.7M-39.3M10.93M11.17M748K-4.75M2M-413K3.03M00
Cash from Investing-210.1M-196.5M-1.76B-326M-251.6M-192.4M-192.7M-158.4M-123.4M-30.2M-21.8M-102.4M-201.9M-60M-93.2M-68.7M-299M-18.2M-47.7M-20.54M12.3M-10.45M-1.51M-10.44M30.47M-7.39M-85.53M-4.44M
Capital Expenditures-89M-90.8M-115.3M-106.9M-129.2M-92M-97.2M-73M-49.2M-43.7M-37.1M-34.2M-33.8M-50.3M-72.8M-54.4M-31.9M-16.3M-47.4M-16.08M-7.62M-3.21M-7.26M-5.49M-15.92M-17.59M-5.58M-4.24M
CapEx % of Revenue2.57%2.64%3.43%3.61%5.11%3.81%4.89%3.52%2.6%2.47%2.3%2.11%1.87%2.73%4.06%3.29%2.44%1.46%4.28%2.94%1.75%1.08%2.55%2.11%13.68%18.98%7.29%6.55%
Acquisitions-88.8M-73.9M-1.6B-226.6M-182.3M-65M-59.2M-90M-191.6M-66.3M-24.3M-28.4M21.4M-11.1M-23.7M-14.3M-269.8M-1.9M-11.4M-4.15M-26.45M-5.61M-5.5M-5.5M-593K022K-200K
Investments----------------------------
Other Investing-32.3M-31.8M1.1M11.1M13.9M4.9M200K11M118.9M11.5M1.1M900K3.1M1.4M3.3M02.7M01.4M-304K-89K-357K5.05M00-1M12.43M0
Cash from Financing-18.6M135.1M1.23B-193.4M-415.3M318.7M-161.6M300M-112.4M-159M-27.2M-168M6.7M26.5M34.4M3.3M168.3M-84.1M-235.1M9.1M-64.39M-7.18M6.77M-8.14M3.53M6.39M104.84M357.67K
Debt Issued (Net)-640.4M-491.3M875.9M-21.5M-110.7M489.7M-8.3M467M-93.5M3.1M145.9M-88.1M-800K17.9M33.3M1.4M163.4M-84.7M173M-10.47M8.05M-11.35M-8.35M2.66M14.2M-10.53M-4.85M357.67K
Equity Issued (Net)-5.5M659.7M403M-142.8M-263.1M-146.3M-119.9M-131.4M9.4M-152.2M-160M-90M7.9M8.2M4.5M3.3M6M1.5M3.7M19.57M1.58M377K14.42M-12K5.11M75.11M109.69M0
Dividends Paid-36.2M-22.8M-30.2M-29.4M-29.8M-24.2M-24.6M-25M-25.1M-25.4M-25.8M00000-100K0-23.4M000000000
Share Repurchases0-10M0-152.3M-263.1M-153.3M-123.2M-142.3M0-152.2M-160M-90M00000000000-12K-3.09M000
Other Financing663.5M-10.5M-18.9M300K-11.7M-500K-8.8M-10.6M-3.2M15.5M12.7M10.1M-400K400K-3.4M-1.4M-1M-900K-25.8M0-74.02M00-10.79M-319K000
Net Change in Cash-50.1M116.4M-304.9M-157.1M-423M386.2M3.6M355.6M-2.6M-17M75.3M-52.4M-119.2M128.1M64.6M15.6M23.3M40.9M-166.2M20.73M-10.48M20.61M7.21M-22.17M23.78M-13.35M19.29M1.31M
Free Cash Flow51.3M43.3M136M243.2M145.2M190.4M235M140.4M190.5M110.7M93.7M195M80.5M94.7M60.3M33.3M124.2M133.5M59.5M12.13M30.07M38.98M-8.15M-11.58M-27.31M-29.07M-5.78M1.2M
FCF Margin %1.48%1.26%4.04%8.2%5.74%7.87%11.82%6.77%10.05%6.27%5.82%12.01%4.45%5.15%3.37%2.02%9.52%11.98%5.37%2.22%6.9%13.1%-2.87%-4.44%-23.47%-31.36%-7.55%1.86%
FCF Growth %-70.62%-68.16%-44.08%67.49%-23.74%-18.98%67.38%-26.3%72.09%18.14%-51.95%142.24%-14.99%57.05%81.08%-73.19%-6.97%124.37%390.52%-59.66%-22.86%578.12%29.57%57.61%6.07%-402.68%-581.29%-
FCF per Share0.340.290.911.650.971.251.520.901.210.700.581.150.470.560.360.200.750.810.360.070.290.39-0.08-0.11-0.52-0.54-0.100.03
FCF Conversion (FCF/Net Income)-4.42x-15.59x2.22x0.82x0.93x1.02x2.11x1.08x1.33x1.96x0.85x2.26x2.02x1.81x1.72x0.95x1.64x1.84x1.65x0.89x2.04x11.57x0.11x0.35x1.84x-3.16x-0.09x4.35x
Interest Paid14.7M054.6M33.7M24.3M19.6M28.7M16M11.7M15.2M12.5M12.2M12.7M12.7M-10.1M6.7M4.5M6.3M10.8M000000000
Taxes Paid38.7M0153.9M96.6M147.4M145.5M43M61.3M60.5M53.1M72.4M56.6M55.9M84.3M-79.9M69.7M38.7M54.2M38.7M000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Integration and cyclical headwinds

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Lacks Cash Support

As reported in financial statements, Bruker's operating cash flow to net income ratio has fluctuated wildly, reaching a negative 16.78 in 2025Q2, which suggests that reported earnings are frequently decoupled from the actual cash generation capabilities of the underlying business operations during this period.

The extreme variance between net income and operating cash flow indicates that non-cash charges and working capital swings are masking the core profitability of the firm. Investors should monitor this divergence, as it suggests that the company's reported earnings may not be a reliable proxy for its ability to fund operations internally.

Free Cash Flow Volatility Persists

Based on Bruker's reported figures, free cash flow margins have swung from a high of 21.2% in 2025Q4 to a low of negative 18.7% in 2025Q2, highlighting the significant instability in cash generation that persists across the company's recent quarterly reporting cycles.

This erratic trajectory appears to be driven by the lumpy nature of high-end instrument installations and the timing of large-scale project payments. The inability to maintain consistent positive free cash flow suggests that the company's current business model remains highly sensitive to timing differences in revenue recognition.

Working Capital Swings Obscure Liquidity

According to recent SEC filings, Bruker experienced a massive working capital outflow of $160.3 million in 2025Q2, a trend that frequently reverses, as seen in the $91.0 million inflow during 2024Q4, indicating significant volatility in the company's ability to manage its short-term operational assets.

These dramatic shifts in working capital suggest that the company's cash position is highly susceptible to inventory build-ups and the timing of customer collections on long-lead-time systems. Such volatility warrants further investigation into whether these fluctuations are purely timing-related or indicative of deeper inefficiencies in the supply chain.

Acquisition Strategy Strains Cash Reserves

As evidenced by the $1.3 billion net acquisition outflow in 2024Q2, Bruker has aggressively utilized its cash resources for inorganic growth, a strategy that appears to be pressuring the company's liquidity and limiting its ability to return capital to shareholders through consistent dividends or buybacks.

The reliance on large-scale acquisitions to drive growth may be diverting capital away from internal R&D and operational improvements. Investors should monitor whether these capital deployments will eventually yield the expected synergies, as the current cash flow profile suggests a high cost of integration.

BRKR — Frequently Asked Questions

Quick answers to the most common questions about buying BRKR stock.

How much cash does Bruker Corporation (BRKR) generate from operations?

Bruker Corporation (BRKR) generated $134.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Bruker Corporation's free cash flow?

Bruker Corporation (BRKR) generated $43.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Bruker Corporation's capital expenditure (CapEx)?

Bruker Corporation (BRKR) spent $90.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Bruker Corporation distribute cash to shareholders?

In 2025, Bruker Corporation (BRKR) returned $22.8M to shareholders via cash dividends and spent $10.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.